(Q53224958)

English

Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.

scientific article published on 30 December 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

cholangiocarcinoma

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Mirko D'Onofrio

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

object named as

Simone Conci

3

0 references

object named as

Rita T Lawlor

5

0 references

Michele Simbolo

object named as

Michele Simbolo

4

0 references

author name string

Andrea Ruzzenente

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Corrado Pedrazzani

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Paola Capelli

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Calogero Iacono

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Alfredo Guglielmi

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

publication date

30 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

23

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

1699-1707

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

https://scigraph.springernature.com/pub.10.1245/s10434-015-5046-6

0 references

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Cholangiocarcinoma--controversies and challenges

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

DNA qualification workflow for next generation sequencing of histopathological samples

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Application of microfluidic technology to the BIOMED-2 protocol for detection of B-cell clonality.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5046-6

21 January 2018

Identifiers

10.1245/S10434-015-5046-6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26717940

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53224958&oldid=1189353780"